Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN) announced novel research into complement biology that both expands the understanding of this important emerging ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE